Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L W Statius van Eps

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
British Medical Journal (Clinical Research Ed.)|August 4, 1984
Comparison of reliability of tests to distinguish upper from lower urinary tract infectionG H Schardijn, L W Statius van Eps, W Pauw, et al.
Clinical Science and Molecular Medicine|November 1, 1978
The tubular reabsorption of phosphate in sickle-cell nephropathyP E De Jong, L T de Jong-van Den Berg, L W Statius van Eps
Annals of the Rheumatic Diseases|August 1, 1982
Prognostic value of anti-dsDNA in SLEA J Swaak, J Groenwold, L A Aarden, et al.
Lancet (London, England)|April 14, 1979
Urinary beta 2 microglobulin in upper and lower urinary-tract infectionsG Schardijn, L W Statius van Eps, A J Swaak, et al.
The Netherlands Journal of Medicine|April 1, 1993
Maternal death due to acute necrotizing colitis in homozygous sickle cell diseaseF W van der Neut, L W Statius van Eps, A van Enk, et al.
International Journal of Oral and Maxillofacial Surgery|October 1, 1987
Osteomyelitis of the jaws in pycnodysostosisJ P van Merkesteyn, J Bras, J I Vermeeren, et al.
Clinical Radiology|September 1, 1989
Imaging the bone marrow with magnetic resonance during a crisis and in chronic forms of sickle cell diseaseT E van Zanten, L W Statius van Eps, R P Golding, et al.
Clinical Chemistry|July 1, 1985
Urinary creatine: biochemical indicator for evaluation of sickle cell crisesC Beyer, L W Statius van Eps, J J Kastelein, et al.
Clinical Nephrology|May 1, 1983
The influence of indomethacin on renal acidification in normal subjects and in patients with sickle cell anemiaP E de Jong, L T de Jong-van den Berg, H Schouten, et al.
Rheumatology International|January 1, 1982
Determination of the half-life of C3 in patients and its relation to the presence of C3-breakdown products and/or circulating immune complexesA J Swaak, A Hannema, C Vogelaar, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
British Medical Journal (Clinical Research Ed.)|August 4, 1984
Comparison of reliability of tests to distinguish upper from lower urinary tract infectionG H Schardijn, L W Statius van Eps, W Pauw, et al.
Clinical Science and Molecular Medicine|November 1, 1978
The tubular reabsorption of phosphate in sickle-cell nephropathyP E De Jong, L T de Jong-van Den Berg, L W Statius van Eps
Annals of the Rheumatic Diseases|August 1, 1982
Prognostic value of anti-dsDNA in SLEA J Swaak, J Groenwold, L A Aarden, et al.
Lancet (London, England)|April 14, 1979
Urinary beta 2 microglobulin in upper and lower urinary-tract infectionsG Schardijn, L W Statius van Eps, A J Swaak, et al.
The Netherlands Journal of Medicine|April 1, 1993
Maternal death due to acute necrotizing colitis in homozygous sickle cell diseaseF W van der Neut, L W Statius van Eps, A van Enk, et al.
International Journal of Oral and Maxillofacial Surgery|October 1, 1987
Osteomyelitis of the jaws in pycnodysostosisJ P van Merkesteyn, J Bras, J I Vermeeren, et al.
Clinical Radiology|September 1, 1989
Imaging the bone marrow with magnetic resonance during a crisis and in chronic forms of sickle cell diseaseT E van Zanten, L W Statius van Eps, R P Golding, et al.
Clinical Chemistry|July 1, 1985
Urinary creatine: biochemical indicator for evaluation of sickle cell crisesC Beyer, L W Statius van Eps, J J Kastelein, et al.
Clinical Nephrology|May 1, 1983
The influence of indomethacin on renal acidification in normal subjects and in patients with sickle cell anemiaP E de Jong, L T de Jong-van den Berg, H Schouten, et al.
Rheumatology International|January 1, 1982
Determination of the half-life of C3 in patients and its relation to the presence of C3-breakdown products and/or circulating immune complexesA J Swaak, A Hannema, C Vogelaar, et al.
Pageof 3